Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-02

Clinical Trial Update: Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating gemcitabine hydrochloride plus genistein for women with stage IV breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemcitabine hydrochloride (Gemcitabine hydrochloride)
  • Genistein (genistein)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-02-02